What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.48%Above 5Y avg (1.35%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
71.4%Moderate
Payback Period
65.8 yr
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.85BCNY
574.41M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
48.04x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Revenue (TTM)
1.47BCNY
219.36M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
5.40%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Beta
0.2900x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-27.19%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
3.85BCNY
574.41M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
3.16BCNY
471.14M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
48.04x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Price to Sales (TTM)
2.62x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Price to Book (MRQ)
3.04x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Enterprise to Revenue
2.15x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Enterprise to EBITDA
26.72x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.79×.Updated Sep 21, 2026
Gross Margin
23.09%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 20.13%.Updated Sep 21, 2026
Profit Margin
5.40%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Operating Margin
5.13%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Return on Assets (TTM)
2.54%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Return on Equity (TTM)
6.12%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Revenue (TTM)
1.47BCNY
219.36M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
5.17CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
11.80%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Gross Profit (TTM)
295.88MCNY
44.15M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
199.93MCNY
29.83M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
79.35MCNY
11.84M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-47.40%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
224.92MCNY
33.56M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
138.31MCNY
20.64M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing Annual Dividend Rate
0.2000CNYUpdated Sep 21, 2026
Trailing Annual Dividend Yield
1.48%
vs all stocks
Updated Sep 21, 2026
5-Year Average Dividend Yield
1.35%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
71.43%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Minority Interest (Equity)
-715.20KCNYFY2025 · Dec 31, 2025
Revenue
1.40BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.06BCNYFY2025 · Dec 31, 2025
Gross Profit
344.85MCNYFY2025 · Dec 31, 2025
Operating Income
146.20MCNY
21.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
150.21MCNYFY2025 · Dec 31, 2025
Income Tax Expense
29.05MCNYFY2025 · Dec 31, 2025
Net Income
121.16MCNYFY2025 · Dec 31, 2025
EBIT
150.57MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
199.93MCNYFY2025 · Dec 31, 2025
Research & Development
86.12MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
64.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.04MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
367.62KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
284.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
284.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
121.16MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.22MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-30.73MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-127.42MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
804.77MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
121.16MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.98MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-75.44MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-81.43MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-96.69MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.16BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.24BCNYFY2025 · Dec 31, 2025
Other Investing Activity
15.94MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
1.51MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
37.90MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-14.64MCNYFY2025 · Dec 31, 2025
Other Financing Charges
98.60KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
23.36MCNYFY2025 · Dec 31, 2025
Shares Outstanding
286.20MSharesUpdated Sep 21, 2026
Float Shares
80.30MSharesUpdated Sep 21, 2026
% Held by Insiders
71.78%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
1.98%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
702.08MCNY
104.76M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
2.45CNYUpdated Sep 21, 2026
Total Debt (MRQ)
11.14MCNY
1.66M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.0088x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Current Ratio (MRQ)
2.23x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
4.42CNYUpdated Sep 21, 2026
Total Assets
1.98BCNY
295.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.50BCNYFY2025 · Dec 31, 2025
Total Liabilities
712.62MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
476.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
21.60MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
691.02MCNYFY2025 · Dec 31, 2025
Cash
804.76MCNYFY2025 · Dec 31, 2025
Cash Equivalents
101.44MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
906.19MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
40.07MCNYFY2025 · Dec 31, 2025
Accounts Receivable
356.50MCNYFY2025 · Dec 31, 2025
Inventory
137.81MCNYFY2025 · Dec 31, 2025
Accounts Payable
571.12MCNYFY2025 · Dec 31, 2025
Short-term Debt
40.16MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.66MCNYFY2025 · Dec 31, 2025
Long-term Debt
747.83KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.68MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
286.20MCNYFY2025 · Dec 31, 2025
Retained Earnings
638.61MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.27BCNY
189.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.61CNYUpdated Sep 21, 2026
52-Week High
27.65CNYUpdated Sep 21, 2026
52-Week Change
-27.19%
vs all stocks
Updated Sep 21, 2026
Beta
0.2900x
vs all stocks
Updated Sep 21, 2026
50-Day MA
14.24CNYUpdated Sep 21, 2026
200-Day MA
18.72CNYUpdated Sep 21, 2026
Avg 10-Day Volume
1.70MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
1.84MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
0.2800CNYUpdated Sep 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 23.1%, lower than 95% of its Scientific & Technical Instruments peers (median 39.1%)Significant